GENX Stock Chart & Stats
$0.02
>-$0.01(-50.00%)
At close: 4:00 PM EDT
$0.02
>-$0.01(-50.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.02
Previous CloseN/A
Volume200.00
Average Volume (3M)0.00
Market Cap
$1.78K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)<0.1
Beta-0.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,846,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GENX FAQ
What was Genex Pharmaceutical Inc’s price range in the past 12 months?
Genex Pharmaceutical Inc lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is Genex Pharmaceutical Inc’s market cap?
Genex Pharmaceutical Inc’s market cap is $1.78K.
When is Genex Pharmaceutical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genex Pharmaceutical Inc’s earnings last quarter?
Currently, no data Available
Is Genex Pharmaceutical Inc overvalued?
According to Wall Street analysts Genex Pharmaceutical Inc’s price is currently Overvalued.
Does Genex Pharmaceutical Inc pay dividends?
Genex Pharmaceutical Inc does not currently pay dividends.
What is Genex Pharmaceutical Inc’s EPS estimate?
Genex Pharmaceutical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genex Pharmaceutical Inc have?
Genex Pharmaceutical Inc has 17,846,000 shares outstanding.
What happened to Genex Pharmaceutical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genex Pharmaceutical Inc?
Currently, no hedge funds are holding shares in GENX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genex Pharmaceutical Inc
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Technical Analysis
China Pharma Holdings
―
PainReform
―
Universe Pharmaceuticals
―
Akanda Corp
―
Shuttle Pharmaceuticals Holdings, Inc.
―